ReNeuron says stem cells improved motor function in stroke study


Biotechnology company ReNeuron Group Plc said its experimental stem cell therapy helped some patients improve motor functions in their arms in a mid-stage study after being disabled by stroke. Shares of the company jumped 22 percent to 3.45 pence per share in morning trade on Monday on the London Stock Exchange.



from Biotech News